Agomab Therapeutics shareholders vote on director nominees Marino Garcia, Naimish Patel at Sept. 11 meeting

• Agomab Therapeutics shareholders will vote Sept. 11, 2026 on adding two non-executive directors to the board.
• Board-backed slate: Marino Garcia, Naimish Patel; each would serve a four-year term ending after the 2030 annual meeting.
• Appointments follow a recommendation from the remuneration, nomination, and corporate governance committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agomab Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-093390), on August 10, 2026, and is solely responsible for the information contained therein.